Pulmonary Endometriosis Successfully Treated with Percutaneous Radiofrequency Ablation: Report of Two Cases.

IF 2.6 3区 医学 Q2 RESPIRATORY SYSTEM
Respiration Pub Date : 2026-04-28 DOI:10.1159/000552095
Yue Cheng, Dan Li, Kaige Wang, Weimin Li, Dan Liu
{"title":"Pulmonary Endometriosis Successfully Treated with Percutaneous Radiofrequency Ablation: Report of Two Cases.","authors":"Yue Cheng, Dan Li, Kaige Wang, Weimin Li, Dan Liu","doi":"10.1159/000552095","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Pulmonary endometriosis (PE) is an unusual cause of catamenial hemoptysis, with only a small proportion of endometriosis cases involving the thorax. Standard management often involves surgical resection combined with hormonal therapy; however, recurrence rates remain high and long-term hormonal suppression can be challenging for patients. Multiple thoracic surgical interventions may be required for these patients during their reproductive age. A more minimally interventional alternative to surgery is expected, especially for those who would like to preserve lung function and warrant quality of life.</p><p><strong>Case presentation: </strong>We report two PE cases diagnosed clinically based on periodical hemoptysis and radiological changes relevant to menstrual cycles. Both patients were successfully treated with percutaneous radiofrequency ablation (RFA), with complete resolution of cyclical hemoptysis and an over 3-year symptom-free follow-up.</p><p><strong>Conclusion: </strong>Percutaneous RFA may be a promising alternative to surgical resection for solitary PE lesions and could serve as part of a multidisciplinary management strategy for endometriosis, especially in young patients at risk of recurrence who wish to preserve lung function and maintain quality of life.</p>","PeriodicalId":21048,"journal":{"name":"Respiration","volume":" ","pages":"1-7"},"PeriodicalIF":2.6000,"publicationDate":"2026-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiration","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000552095","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Pulmonary endometriosis (PE) is an unusual cause of catamenial hemoptysis, with only a small proportion of endometriosis cases involving the thorax. Standard management often involves surgical resection combined with hormonal therapy; however, recurrence rates remain high and long-term hormonal suppression can be challenging for patients. Multiple thoracic surgical interventions may be required for these patients during their reproductive age. A more minimally interventional alternative to surgery is expected, especially for those who would like to preserve lung function and warrant quality of life.

Case presentation: We report two PE cases diagnosed clinically based on periodical hemoptysis and radiological changes relevant to menstrual cycles. Both patients were successfully treated with percutaneous radiofrequency ablation (RFA), with complete resolution of cyclical hemoptysis and an over 3-year symptom-free follow-up.

Conclusion: Percutaneous RFA may be a promising alternative to surgical resection for solitary PE lesions and could serve as part of a multidisciplinary management strategy for endometriosis, especially in young patients at risk of recurrence who wish to preserve lung function and maintain quality of life.

经皮射频消融术成功治疗肺子宫内膜异位症2例报告。
肺子宫内膜异位症(PE)是一种罕见的引起羊膜咯血的原因,只有一小部分子宫内膜异位症的病例累及胸腔。标准治疗通常包括手术切除联合激素治疗;然而,复发率仍然很高,长期激素抑制对患者来说可能具有挑战性。这些患者在育龄期间可能需要多次胸外科手术干预。对于那些希望保持肺功能和保证生活质量的患者,期望有一种比手术更低干预的替代方法。病例介绍:我们报告两例PE病例,临床诊断基于周期性咯血和与月经周期相关的放射学变化。两例患者均成功接受经皮射频消融(RFA)治疗,周期性咯血完全消退,随访3年无症状。结论:经皮射频消融可能是手术切除孤立性PE病变的一种有希望的替代方法,可以作为子宫内膜异位症多学科治疗策略的一部分,特别是对于希望保持肺功能和维持生活质量的复发风险的年轻患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Respiration
Respiration 医学-呼吸系统
CiteScore
7.30
自引率
5.40%
发文量
82
审稿时长
4-8 weeks
期刊介绍: ''Respiration'' brings together the results of both clinical and experimental investigations on all aspects of the respiratory system in health and disease. Clinical improvements in the diagnosis and treatment of chest and lung diseases are covered, as are the latest findings in physiology, biochemistry, pathology, immunology and pharmacology. The journal includes classic features such as editorials that accompany original articles in clinical and basic science research, reviews and letters to the editor. Further sections are: Technical Notes, The Eye Catcher, What’s Your Diagnosis?, The Opinion Corner, New Drugs in Respiratory Medicine, New Insights from Clinical Practice and Guidelines. ''Respiration'' is the official journal of the Swiss Society for Pneumology (SGP) and also home to the European Association for Bronchology and Interventional Pulmonology (EABIP), which occupies a dedicated section on Interventional Pulmonology in the journal. This modern mix of different features and a stringent peer-review process by a dedicated editorial board make ''Respiration'' a complete guide to progress in thoracic medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书